Drug allergy

References

• Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. BMJ 1998; 316:1295 - 8; http://dx.doi.org/10.1136/bmj.316.7140.1295; PMID: 9554902
   PubMed Web of Science ®Google Scholar
• Pichler WJ, Naisbitt DJ, Park BK. Immune pathomechanism of drug hypersensitivity reactions. J Allergy Clin Immunol 2011; 127:Suppl S74 - 81; http://dx.doi.org/10.1016/j.jaci.2010.11.048; PMID: 21354503
   PubMed Web of Science ®Google Scholar
• McKinnon RP, Wildsmith JA. Histaminoid reactions in anaesthesia. Br J Anaesth 1995; 74:217 - 28; http://dx.doi.org/10.1093/bja/74.2.217; PMID: 7535078
   PubMed Web of Science ®Google Scholar
• Idsoe O, Guthe T, Willcox RR, de Weck AL. Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull World Health Organ 1968; 38:159 - 88; PMID: 5302296
   PubMed Web of Science ®Google Scholar
• Meng X, Jenkins RE, Berry NG, Maggs JL, Farrell J, Lane CS, et al. Direct evidence for the formation of diastereoisomeric benzylpenicilloyl haptens from benzylpenicillin and benzylpenicillenic acid in patients. J Pharmacol Exp Ther 2011; 338:841 - 9; http://dx.doi.org/10.1124/jpet.111.183871; PMID: 21680886
   PubMed Web of Science ®Google Scholar
• El-Ghaiesh S, Monshi MM, Whitaker P, Jenkins R, Meng X, Farrell J, et al. Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis. J Pharmacol Exp Ther 2012; 341:597 - 610; http://dx.doi.org/10.1124/jpet.111.190900; PMID: 22371438
   PubMed Web of Science ®Google Scholar
• Levine BB. Immunologic mechanisms of penicillin allergy. A haptenic model system for the study of allergic diseases of man. N Engl J Med 1966; 275:1115 - 25; http://dx.doi.org/10.1056/NEJM196611172752009; PMID: 5923027
   PubMed Web of Science ®Google Scholar
• Pichler WJ. Immune mechanism of drug hypersensitivity. Immunol Allergy Clin North Am 2004; 24:373 - 97, v-vi; http://dx.doi.org/10.1016/j.iac.2004.03.012; PMID: 15242717
   PubMed Web of Science ®Google Scholar
• Perez-Inestrosa E, Suau R, Montañez MI, Rodriguez R, Mayorga C, Torres MJ, et al. Cephalosporin chemical reactivity and its immunological implications. Curr Opin Allergy Clin Immunol 2005; 5:323 - 30; http://dx.doi.org/10.1097/01.all.0000173788.73401.69; PMID: 15985814
   PubMed Web of Science ®Google Scholar
• Elsheikh A, Castrejon L, Lavergne SN, Whitaker P, Monshi M, Callan H, et al. Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosis. J Allergy Clin Immunol 2011; 127:1543 - 51, e3; http://dx.doi.org/10.1016/j.jaci.2010.12.1119; PMID: 21354601
   PubMed Web of Science ®Google Scholar
• Wang D, Para MF, Koletar SL, Sadee W. Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity. Pharmacogenet Genomics 2011; 21:652 - 64; http://dx.doi.org/10.1097/FPC.0b013e3283498ee9; PMID: 21878835
   PubMed Web of Science ®Google Scholar
• Zaheer-ul-Haq, Khan W. Molecular and structural determinants of adamantyl susceptibility to HLA-DRs allelic variants: an in silico approach to understand the mechanism of MLEs. J Comput Aided Mol Des 2011; 25:81 - 101; http://dx.doi.org/10.1007/s10822-010-9404-y; PMID: 21116684
   PubMed Web of Science ®Google Scholar
• Pichler WJ. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allergy Clin Immunol 2002; 2:301 - 5; http://dx.doi.org/10.1097/00130832-200208000-00003; PMID: 12130944
   PubMed Web of Science ®Google Scholar
• IUPAC recommendation on nomenclature and symbols. Clinical Chemistry Division. Commision on Toxicology. Glossary of terms used in toxicology synopsis. Acta Pol Pharm 1992; 49:1; PMID: 16092424
   PubMedGoogle Scholar
• Uetrecht J. Idiosyncratic drug reactions: current understanding. Annu Rev Pharmacol Toxicol 2007; 47:513 - 39; http://dx.doi.org/10.1146/annurev.pharmtox.47.120505.105150; PMID: 16879083
   PubMed Web of Science ®Google Scholar
• Posadas SJ, Pichler WJ. Delayed drug hypersensitivity reactions - new concepts. Clin Exp Allergy 2007; 37:989 - 99; http://dx.doi.org/10.1111/j.1365-2222.2007.02742.x; PMID: 17581192
   PubMed Web of Science ®Google Scholar
• Lavergne SN, Wang H, Callan HE, Park BK, Naisbitt DJ. “Danger” conditions increase sulfamethoxazole-protein adduct formation in human antigen-presenting cells. J Pharmacol Exp Ther 2009; 331:372 - 81; http://dx.doi.org/10.1124/jpet.109.155374; PMID: 19666748
   PubMed Web of Science ®Google Scholar
• Sanderson JP, Naisbitt DJ, Farrell J, Ashby CA, Tucker MJ, Rieder MJ, et al. Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling. J Immunol 2007; 178:5533 - 42; PMID: 17442935
   PubMed Web of Science ®Google Scholar
• Elsheikh A, Lavergne SN, Castrejon JL, Farrell J, Wang H, Sathish J, et al. Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism. J Immunol 2010; 185:6448 - 60; http://dx.doi.org/10.4049/jimmunol.1000889; PMID: 20980635
   PubMed Web of Science ®Google Scholar
• Martin AM, Almeida CA, Cameron P, Purcell AW, Nolan D, James I, et al. Immune responses to abacavir in antigen-presenting cells from hypersensitive patients. AIDS 2007; 21:1233 - 44; http://dx.doi.org/10.1097/QAD.0b013e3280119579; PMID: 17545699
   PubMed Web of Science ®Google Scholar
• Kano Y, Shiohara T. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol Allergy Clin North Am 2009; 29:481 - 501; http://dx.doi.org/10.1016/j.iac.2009.04.007; PMID: 19563993
   PubMed Web of Science ®Google Scholar
• Hanafusa T, Azukizawa H, Matsumura S, Katayama I. The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity. J Dermatol Sci 2012; 65:213 - 9; http://dx.doi.org/10.1016/j.jdermsci.2011.12.002; PMID: 22226608
   PubMed Web of Science ®Google Scholar
• Illing PT, Vivian JP, Dudek NL, Kostenko L, Chen Z, Bharadwaj M, et al. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 2012; 486:554 - 8; PMID: 22722860
   PubMed Web of Science ®Google Scholar
• Adam J, Eriksson KK, Schnyder B, Fontana S, Pichler WJ, Yerly D. Avidity determines T-cell reactivity in abacavir hypersensitivity. Eur J Immunol 2012; 42:1706 - 16; http://dx.doi.org/10.1002/eji.201142159; PMID: 22585534
   PubMed Web of Science ®Google Scholar
• Chessman D, Kostenko L, Lethborg T, Purcell AW, Williamson NA, Chen Z, et al. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity. Immunity 2008; 28:822 - 32; http://dx.doi.org/10.1016/j.immuni.2008.04.020; PMID: 18549801
   PubMed Web of Science ®Google Scholar
• Llano A, Brander C. Mechanisms involved in the Abacavir-mediated hypersensitivity syndrome. Cell Res 2012; http://dx.doi.org/10.1038/cr.2012.105; PMID: 22777424
   PubMed Web of Science ®Google Scholar
• Pirmohamed M. Genetics and the potential for predictive tests in adverse drug reactions. Chem Immunol Allergy 2012; 97:18 - 31; http://dx.doi.org/10.1159/000335613; PMID: 22613851
   PubMedGoogle Scholar
• Bharadwaj M, Illing P, Theodossis A, Purcell AW, Rossjohn J, McCluskey J. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex. Annu Rev Pharmacol Toxicol 2012; 52:401 - 31; http://dx.doi.org/10.1146/annurev-pharmtox-010611-134701; PMID: 22017685
   PubMed Web of Science ®Google Scholar
• McCormack M, Alfirevic A, Bourgeois S, Farrell JJ, Kasperavičiūtė D, Carrington M, et al. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med 2011; 364:1134 - 43; http://dx.doi.org/10.1056/NEJMoa1013297; PMID: 21428769
   PubMed Web of Science ®Google Scholar
• Ko TM, Chung WH, Wei CY, Shih HY, Chen JK, Lin CH, et al. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome. J Allergy Clin Immunol 2011; 128:1266 - 76, e11; http://dx.doi.org/10.1016/j.jaci.2011.08.013; PMID: 21924464
   PubMed Web of Science ®Google Scholar
• Chung WH, Hung SI. Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis. J Dermatol Sci 2012; 66:190 - 6; http://dx.doi.org/10.1016/j.jdermsci.2012.04.002; PMID: 22541332
   PubMed Web of Science ®Google Scholar
• Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282:490 - 3; http://dx.doi.org/10.1126/science.282.5388.490; PMID: 9774279
   PubMed Web of Science ®Google Scholar
• Nassif A, Bensussan A, Dorothée G, Mami-Chouaib F, Bachot N, Bagot M, et al. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis. J Invest Dermatol 2002; 118:728 - 33; http://dx.doi.org/10.1046/j.1523-1747.2002.01622.x; PMID: 11918724
   PubMed Web of Science ®Google Scholar
• Shiohara T, Kano Y. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol 2007; 33:124 - 33; http://dx.doi.org/10.1007/s12016-007-8010-9; PMID: 18094951
   PubMed Web of Science ®Google Scholar
• Takahashi R, Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, Shiohara T. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 2009; 182:8071 - 9; http://dx.doi.org/10.4049/jimmunol.0804002; PMID: 19494333
   PubMed Web of Science ®Google Scholar
• Criado PR, Criado RF, Avancini Jde M, Santi CG. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome: a review of current concepts. An Bras Dermatol 2012; 87:435 - 49; http://dx.doi.org/10.1590/S0365-05962012000300013; PMID: 22714760
   PubMed Web of Science ®Google Scholar
• Ju C, Reilly T. Role of immune reactions in drug-induced liver injury (DILI). Drug Metab Rev 2012; 44:107 - 15; http://dx.doi.org/10.3109/03602532.2011.645579; PMID: 22235834
   PubMed Web of Science ®Google Scholar
• Tujios S, Fontana RJ. Mechanisms of drug-induced liver injury: from bedside to bench. Nat Rev Gastroenterol Hepatol 2011; 8:202 - 11; http://dx.doi.org/10.1038/nrgastro.2011.22; PMID: 21386809
   PubMed Web of Science ®Google Scholar
• You Q, Cheng L, Reilly TP, Wegmann D, Ju C. Role of neutrophils in a mouse model of halothane-induced liver injury. Hepatology 2006; 44:1421 - 31; http://dx.doi.org/10.1002/hep.21425; PMID: 17133481
   PubMed Web of Science ®Google Scholar
• Jenkins RE, Meng X, Elliott VL, Kitteringham NR, Pirmohamed M, Park BK. Characterisation of flucloxacillin and 5-hydroxymethyl flucloxacillin haptenated HSA in vitro and in vivo. Proteomics Clin Appl 2009; 3:720 - 9; http://dx.doi.org/10.1002/prca.200800222; PMID: 21136982
   PubMed Web of Science ®Google Scholar
• Alfirevic A, Gonzalez-Galarza F, Bell C, Martinsson K, Platt V, Bretland G, et al. In silico analysis of HLA associations with drug-induced liver injury: use of a HLA-genotyped DNA archive from healthy volunteers. Genome Med 2012; 4:51; http://dx.doi.org/10.1186/gm350; PMID: 22732016
   PubMedGoogle Scholar
• Daly AK. Drug-induced liver injury: past, present and future. Pharmacogenomics 2010; 11:607 - 11; http://dx.doi.org/10.2217/pgs.10.24; PMID: 20415545
   PubMed Web of Science ®Google Scholar
• Philp JR. Allergic Drug Reactions.; In: Walker HK, Hall WD, Hurst JW Ed. Clinical Methods: The History, Physical, and Laboratory Examinations. Boston, Butterworth Publishers 1990; Chapter 24.
   Google Scholar
• Bloemen K, Verstraelen S, Van Den Heuvel R, Witters H, Nelissen I, Schoeters G. The allergic cascade: review of the most important molecules in the asthmatic lung. Immunol Lett 2007; 113:6 - 18; http://dx.doi.org/10.1016/j.imlet.2007.07.010; PMID: 17765979
   PubMed Web of Science ®Google Scholar
• Garratty G. Immune hemolytic anemia caused by drugs. Expert Opin Drug Saf 2012; 11:635 - 42; http://dx.doi.org/10.1517/14740338.2012.678832; PMID: 22502777
   PubMed Web of Science ®Google Scholar
• Castells M, Sancho-Serra MD, Simarro M. Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization. Cancer Immunol Immunother 2012; http://dx.doi.org/10.1007/s00262-012-1273-x; PMID: 22576054
   PubMed Web of Science ®Google Scholar
• Adam J, Pichler WJ, Yerly D. Delayed drug hypersensitivity: models of T-cell stimulation. Br J Clin Pharmacol 2011; 71:701 - 7; http://dx.doi.org/10.1111/j.1365-2125.2010.03764.x; PMID: 21480949
   PubMed Web of Science ®Google Scholar
• Glimcher LH, Murphy KM. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev 2000; 14:1693 - 711; PMID: 10898785
   PubMed Web of Science ®Google Scholar
• Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008; 8:337 - 48; http://dx.doi.org/10.1038/nri2295; PMID: 18408735
   PubMed Web of Science ®Google Scholar
• Hochrein H, O’Keeffe M. Dendritic cell subsets and toll-like receptors. Handb Exp Pharmacol 2008; 183:153 - 79; http://dx.doi.org/10.1007/978-3-540-72167-3_8; PMID: 18071659
   PubMedGoogle Scholar
• Nakanishi K. Basophils are potent antigen-presenting cells that selectively induce Th2 cells. Eur J Immunol 2010; 40:1836 - 42; http://dx.doi.org/10.1002/eji.201040588; PMID: 20518033
   PubMed Web of Science ®Google Scholar
• Daubner B, Groux-Keller M, Hausmann OV, Kawabata T, Naisbitt DJ, Park BK, et al. Multiple drug hypersensitivity: normal Treg cell function but enhanced in vivo activation of drug-specific T cells. Allergy 2012; 67:58 - 66; http://dx.doi.org/10.1111/j.1398-9995.2011.02720.x; PMID: 21933197
   PubMed Web of Science ®Google Scholar
• Muh HC, Tong JC, Tammi MT. AllerHunter: a SVM-pairwise system for assessment of allergenicity and allergic cross-reactivity in proteins. PLoS One 2009; 4:e5861; http://dx.doi.org/10.1371/journal.pone.0005861; PMID: 19516900
   PubMed Web of Science ®Google Scholar
• Traidl-Hoffmann C, Jakob T, Behrendt H. Determinants of allergenicity. J Allergy Clin Immunol 2009; 123:558 - 66; http://dx.doi.org/10.1016/j.jaci.2008.12.003; PMID: 19152966
   PubMed Web of Science ®Google Scholar
• Palikhe NS, Kim SH, Nam YH, Ye YM, Park HS. Polymorphisms of Aspirin-Metabolizing Enzymes CYP2C9, NAT2 and UGT1A6 in Aspirin-Intolerant Urticaria. Allergy Asthma Immunol Res 2011; 3:273 - 6; http://dx.doi.org/10.4168/aair.2011.3.4.273; PMID: 21966608
   PubMedGoogle Scholar
• Di Lorenzo G, Pacor ML, Candore G, Listi F, Ditta V, Leto-Barone MS, et al. Polymorphisms of cyclo-oxygenases and 5-lipo-oxygenase-activating protein are associated with chronic spontaneous urticaria and urinary leukotriene E4. Eur J Dermatol 2011; 21:47 - 52; PMID: 21227888
   PubMed Web of Science ®Google Scholar
• Stevenson DD. Aspirin sensitivity and desensitization for asthma and sinusitis. Curr Allergy Asthma Rep 2009; 9:155 - 63; http://dx.doi.org/10.1007/s11882-009-0023-4; PMID: 19210906
   PubMed Web of Science ®Google Scholar
• Rizk H. Role of aspirin desensitization in the management of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2011; 19:210 - 7; http://dx.doi.org/10.1097/MOO.0b013e3283450102; PMID: 21372715
   PubMed Web of Science ®Google Scholar
• Vasekar M, Craig TJ. ACE inhibitor-induced angioedema. Curr Allergy Asthma Rep 2012; 12:72 - 8; http://dx.doi.org/10.1007/s11882-011-0238-z; PMID: 22127615
   PubMed Web of Science ®Google Scholar
• Torres MJ, Blanca M. The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams. [xii.] Med Clin North Am 2010; 94:805 - 20, xii; http://dx.doi.org/10.1016/j.mcna.2010.04.006; PMID: 20609864
   PubMed Web of Science ®Google Scholar
• Warrington R, Silviu-Dan F. Drug allergy. Allergy Asthma Clin Immunol 2011; 7:Suppl 1 S10; http://dx.doi.org/10.1186/1710-1492-7-S1-S10; PMID: 22165859
   PubMedGoogle Scholar
• Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med 2003; 349:1628 - 35; http://dx.doi.org/10.1056/NEJMoa022963; PMID: 14573734
   PubMed Web of Science ®Google Scholar
• Zawodniak A, Lochmatter P, Beeler A, Pichler WJ. Cross-reactivity in drug hypersensitivity reactions to sulfasalazine and sulfamethoxazole. Int Arch Allergy Immunol 2010; 153:152 - 6; http://dx.doi.org/10.1159/000312632; PMID: 20413982
   PubMed Web of Science ®Google Scholar
• Weberschock TB, Müller SM, Boehncke S, Boehncke WH. Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literature. Arch Dermatol Res 2007; 299:169 - 75; http://dx.doi.org/10.1007/s00403-007-0757-6; PMID: 17492455
   PubMed Web of Science ®Google Scholar
• Chaudhry T, Hissaria P, Wiese M, Heddle R, Kette F, Smith WB. Oral drug challenges in non-steroidal anti-inflammatory drug-induced urticaria, angioedema and anaphylaxis. Intern Med J 2012; 42:665 - 71; http://dx.doi.org/10.1111/j.1445-5994.2011.02601.x; PMID: 21981353
   PubMed Web of Science ®Google Scholar
• Gallitelli M, Alzetta M. Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors. Am J Emerg Med 2011; http://dx.doi.org/10.1016/j.ajem.2011.09.014; PMID: 22100478
   PubMed Web of Science ®Google Scholar
• Mertes PM, Demoly P, Malinovsky JM. Hypersensitivity reactions in the anesthesia setting/allergic reactions to anesthetics. Curr Opin Allergy Clin Immunol 2012; 12:361 - 8; http://dx.doi.org/10.1097/ACI.0b013e328355b82f; PMID: 22766618
   PubMed Web of Science ®Google Scholar
• Liu A, Fanning L, Chong H, Fernandez J, Sloane D, Sancho-Serra M, et al. Desensitization regimens for drug allergy: state of the art in the 21st century. Clin Exp Allergy 2011; 41:1679 - 89; http://dx.doi.org/10.1111/j.1365-2222.2011.03825.x; PMID: 21883538
   PubMed Web of Science ®Google Scholar
• Neuman MG, Cohen L, Nanau RM, Hwang PA. Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs. Transl Res 2012; 159:397 - 406; http://dx.doi.org/10.1016/j.trsl.2012.01.004; PMID: 22500513
   PubMed Web of Science ®Google Scholar
• Daly AK, Day CP. Genetic association studies in drug-induced liver injury. Drug Metab Rev 2012; 44:116 - 26; http://dx.doi.org/10.3109/03602532.2011.605790; PMID: 21913872
   PubMed Web of Science ®Google Scholar
• Cernadas JR, Brockow K, Romano A, Aberer W, Torres MJ, Bircher A, et al, European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity. General considerations on rapid desensitization for drug hypersensitivity - a consensus statement. Allergy 2010; 65:1357 - 66; http://dx.doi.org/10.1111/j.1398-9995.2010.02441.x; PMID: 20716314
   PubMed Web of Science ®Google Scholar
• de Groot H, Mulder WM. Clinical practice: drug desensitization in children. Eur J Pediatr 2010; 169:1305 - 9; http://dx.doi.org/10.1007/s00431-010-1236-1; PMID: 20571825
   PubMed Web of Science ®Google Scholar
• Woo HY, Kim YS, Kang NI, Chung WC, Song CH, Choi IW, et al. Mechanism for acute oral desensitization to antibiotics. Allergy 2006; 61:954 - 8; http://dx.doi.org/10.1111/j.1398-9995.2006.01147.x; PMID: 16867049
   PubMed Web of Science ®Google Scholar
• Park JS, Choi IH, Lee DG, Han SS, Ha TY, Lee JH, et al. Anti-IL-4 monoclonal antibody prevents antibiotics-induced active fatal anaphylaxis. J Immunol 1997; 158:5002 - 6; PMID: 9144520
   PubMed Web of Science ®Google Scholar
• del Carmen Sancho M, Breslow R, Sloane D, Castells M. Desensitization for hypersensitivity reactions to medications. Chem Immunol Allergy 2012; 97:217 - 33; http://dx.doi.org/10.1159/000335637; PMID: 22613865
   PubMedGoogle Scholar
• MacGlashan DJ Jr.. Subthreshold desensitization of human basophils re-capitulates the loss of Syk and FcεRI expression characterized by other methods of desensitization. Clin Exp Allergy 2012; 42:1060 - 70; http://dx.doi.org/10.1111/j.1365-2222.2012.04013.x; PMID: 22702505
   PubMed Web of Science ®Google Scholar
• De Weck AL, Jeunet F, Schulz KH, Louis P, Girard JP, Grilliat JP, et al. Clinical trial of Ro 6-0787, a monovalent specific hapten inhibitor of penicillin allergy. Z Immunitatsforsch Exp Klin Immunol 1975; 150:138 - 60; PMID: 127471
   PubMedGoogle Scholar
• Stevenson DD, Simon RA, Mathison DA. Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol 1980; 66:82 - 8; http://dx.doi.org/10.1016/0091-6749(80)90143-8; PMID: 7381126
   PubMed Web of Science ®Google Scholar
• Stevenson DD, Pleskow WW, Simon RA, Mathison DA, Lumry WR, Schatz M, et al. Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin. J Allergy Clin Immunol 1984; 73:500 - 7; http://dx.doi.org/10.1016/0091-6749(84)90361-0; PMID: 6368649
   PubMed Web of Science ®Google Scholar
• Sweet JM, Stevenson DD, Simon RA, Mathison DA. Long-term effects of aspirin desensitization--treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol 1990; 85:59 - 65; http://dx.doi.org/10.1016/0091-6749(90)90222-P; PMID: 2299107
   PubMed Web of Science ®Google Scholar
• Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2003; 111:180 - 6; http://dx.doi.org/10.1067/mai.2003.7; PMID: 12532116
   PubMed Web of Science ®Google Scholar
• Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 1996; 98:751 - 8; http://dx.doi.org/10.1016/S0091-6749(96)70123-9; PMID: 8876550
   PubMed Web of Science ®Google Scholar
• Parikh AA, Scadding GK. Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial. Laryngoscope 2005; 115:1385 - 90; http://dx.doi.org/10.1097/01.MLG.0000166702.38850.1B; PMID: 16094110
   PubMed Web of Science ®Google Scholar
• Ogata N, Darby Y, Scadding G. Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma. J Laryngol Otol 2007; 121:1156 - 60; http://dx.doi.org/10.1017/S0022215107000515; PMID: 17697437
   PubMed Web of Science ®Google Scholar
• Cianferoni A, Schroeder JT, Kim J, Schmidt JW, Lichtenstein LM, Georas SN, et al. Selective inhibition of interleukin-4 gene expression in human T cells by aspirin. Blood 2001; 97:1742 - 9; http://dx.doi.org/10.1182/blood.V97.6.1742; PMID: 11238116
   PubMed Web of Science ®Google Scholar
• Turcanu V, Maleki SJ, Lack G. Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts. J Clin Invest 2003; 111:1065 - 72; PMID: 12671056
   PubMed Web of Science ®Google Scholar
• Tsuge I, Okumura A, Kondo Y, Itomi S, Kakami M, Kawamura M, et al. Allergen-specific T-cell response in patients with phenytoin hypersensitivity; simultaneous analysis of proliferation and cytokine production by carboxyfluorescein succinimidyl ester (CFSE) dilution assay. Allergol Int 2007; 56:149 - 55; http://dx.doi.org/10.2332/allergolint.O-06-457; PMID: 17460442
   PubMedGoogle Scholar
• Okumura A, Tsuge I, Kubota T, Kurahashi H, Natsume J, Negoro T, et al. Phenytoin desensitization monitored by antigen specific T cell response using carboxyfluorescein succinimidyl ester dilution assay. Eur J Paediatr Neurol 2007; 11:385 - 8; http://dx.doi.org/10.1016/j.ejpn.2007.03.001; PMID: 17428709
   PubMed Web of Science ®Google Scholar
• Mizukawa Y, Yamazaki Y, Shiohara T. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption. Br J Dermatol 2008; 158:1230 - 8; http://dx.doi.org/10.1111/j.1365-2133.2008.08516.x; PMID: 18363767
   PubMed Web of Science ®Google Scholar
• Mizukawa Y, Shiohara T. Fixed drug eruption: a prototypic disorder mediated by effector memory T cells. Curr Allergy Asthma Rep 2009; 9:71 - 7; http://dx.doi.org/10.1007/s11882-009-0011-8; PMID: 19063828
   PubMed Web of Science ®Google Scholar
• Teraki Y, Shiohara T. Successful desensitization to fixed drug eruption: the presence of CD25+CD4+ T cells in the epidermis of fixed drug eruption lesions may be involved in the induction of desensitization. Dermatology 2004; 209:29 - 32; http://dx.doi.org/10.1159/000078583; PMID: 15237264
   PubMed Web of Science ®Google Scholar
• Lin D, Li WK, Rieder MJ. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole. Cochrane Database Syst Rev 2007; CD005646; PMID: 17443608
   PubMedGoogle Scholar
• Fam AG, Dunne SM, Iazzetta J, Paton TW. Efficacy and safety of desensitization to allopurinol following cutaneous reactions. Arthritis Rheum 2001; 44:231 - 8; http://dx.doi.org/10.1002/1529-0131(200101)44:1<231::AID-ANR30>3.0.CO;2-7; PMID: 11212165
   PubMed Web of Science ®Google Scholar
• Demoly P, Messaad D, Sahla H, Fabre J, Faucherre V, André P, et al. Six-hour trimethoprim-sulfamethoxazole-graded challenge in HIV-infected patients. J Allergy Clin Immunol 1998; 102:1033 - 6; http://dx.doi.org/10.1016/S0091-6749(98)70343-4; PMID: 9847446
   PubMed Web of Science ®Google Scholar
• Cernadas JR, Brockow K, Romano A, Aberer W, Torres MJ, Bircher A, et al, European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity. General considerations on rapid desensitization for drug hypersensitivity - a consensus statement. Allergy 2010; 65:1357 - 66; http://dx.doi.org/10.1111/j.1398-9995.2010.02441.x; PMID: 20716314
   PubMed Web of Science ®Google Scholar
• Vultaggio A, Maggi E, Matucci A. Immediate adverse reactions to biologicals: from pathogenic mechanisms to prophylactic management. Curr Opin Allergy Clin Immunol 2011; 11:262 - 8; http://dx.doi.org/10.1097/ACI.0b013e3283464bcd; PMID: 21460715
   PubMed Web of Science ®Google Scholar
• Yoshizawa S, Yasuoka A, Kikuchi Y, Honda M, Gatanaga H, Tachikawa N, et al. A 5-day course of oral desensitization to trimethoprim/sulfamethoxazole (T/S) in patients with human immunodeficiency virus type-1 infection who were previously intolerant to T/S. Ann Allergy Asthma Immunol 2000; 85:241 - 4; http://dx.doi.org/10.1016/S1081-1206(10)62474-X; PMID: 11030281
   PubMed Web of Science ®Google Scholar